Related references
Note: Only part of the references are listed.TERT promoter mutations in cancer development
Barbara Heidenreich et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
T. Liu et al.
ONCOGENE (2014)
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
Barbara Heidenreich et al.
NATURE COMMUNICATIONS (2014)
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Kun Wang et al.
ONCOTARGET (2014)
Physiological and pathological significance of human telomerase reverse transcriptase splice variants
F. Mathias Bollmann
BIOCHIMIE (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Telomerase and the search for the end of cancer
Simone Mocellin et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
Zhihu Ding et al.
CELL (2012)
Wnt Regulates TERT-Putting the Horse Before the Cart
Carol W. Greider
SCIENCE (2012)
Role of VHL gene mutation in human renal cell carcinoma
Wani Arjumand et al.
TUMOR BIOLOGY (2012)
A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer
Min Shen et al.
LUNG CANCER (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Alterations in VHL as potential biomarkers in renal-cell carcinoma
Lucy Gossage et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Satoru Kyo et al.
CANCER SCIENCE (2008)
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc
Dakang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Genes and pathways downstream of telomerase in melanoma metastasis
Sepideh Bagheri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues
YD Fan et al.
CLINICAL CANCER RESEARCH (2005)
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
JK Maranchie et al.
HUMAN MUTATION (2004)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Share Paper
